Activities of Corinne LEPAGE related to 2012/2066(INI)
Shadow reports (1)
REPORT on the protection of public health from endocrine disrupters PDF (191 KB) DOC (126 KB)
Amendments (17)
Amendment 2 #
Motion for a resolution
Heading 1
Heading 1
on the protection of public health and environment from endocrine disrupters
Amendment 14 #
Motion for a resolution
Recital A
Recital A
A. whereas hormone-related disorders and illnesses in humans have increased over the last 20 years, including impaired sperm quality, early onset of puberty, increased incidence of deformed sexual organs, increased incidence of certain forms of cancer and many cases of metabolic, metabolic diseases, and impacts on neurodevelopmental functions, the immune system or epigenetics ; whereas the growing economic and social costs of these hormone-related disorders and illnesses ;
Amendment 31 #
Motion for a resolution
Recital E
Recital E
E. whereas EU legislation contains no criteria for determining whether a substance should be regarded as having endocrine-disrupting properties; whereas a timetable should be set up to ensure the swift application of the future criteria.
Amendment 48 #
Motion for a resolution
Paragraph 1 a (new)
Paragraph 1 a (new)
1a. Points out that the precautionary principle applies in a world of scientific uncertainty, in which a risk can be characterised only on the basis of imperfect knowledge – neither set in stone nor beyond challenge – but in which it is necessary to act in order to avert or reduce potentially serious or irreversible consequences for human health and/or the environment; considers that the Commission, as a risk manager, is duty- bound to observe that principle, in accordance with Article 191(2) of the Treaty on the Functioning of the EU (TFEU); maintains, as far as endocrine disruptors are concerned, that the precautionary principle should lead the Commission to bring a much greater research effort to bear to improve the state of scientific knowledge, as well as to propose a range of measures, including some to be implemented immediately, with a view to protecting the public and the environment and informing groups most at risk;
Amendment 81 #
Motion for a resolution
Paragraph 6
Paragraph 6
6. Stresses that the criteria determining what constitutes an endocrine disruptor should be scientifically based and that the precautionary principle should be applied; considers that a socio-economic assessment should then be carried out in accordance with the relevant legislation;
Amendment 85 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Takes the view that all peer-reviewed scientific data and information, including a review of the scientific literature and non-GLP studies, should be taken into account, subject to their strengths and weaknesses, in assessing whether a substance does or does not have endocrine- disrupting properties; further considers it important to take account of modern methods and up-to-date research;
Amendment 92 #
Motion for a resolution
Paragraph 8
Paragraph 8
8. Calls on the Commission to introduce in all relevant EU legislation appropriate testing requirements for the identification of substances with endocrine-disrupting properties; considers that the most recent validated and internationally recognised testing methods that have been developed in (for example) the OECD must be implemented; notes that the OECD programme of testing methods covers sex hormones and thyroid hormones as well as steroidogenesis; points out, on the other hand, that there are no tests for other areas of the endocrine system, e.g. insulin and growth hormones; considers that testing methods and guidance documents should be developed so as to take better account of endocrine disruptors, possible low-dose effects and non- monotonic dose-response relationships;
Amendment 93 #
Motion for a resolution
Paragraph 8 a (new)
Paragraph 8 a (new)
8 a. Invites the Commission and Member States to develop registers of reproductive health disorders to fill the existing data gap at EU level ;
Amendment 94 #
Motion for a resolution
Paragraph 8 b (new)
Paragraph 8 b (new)
8 b. Invites the Commission and Member States to develop reliable data on the socio-economic impacts of hormone- related disorders and illnesses
Amendment 108 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Calls on the Commission, in its review of EU strategy on endocrine disruptors, to place greater emphasis on the precautionary principle and work towards reducing human and environment exposure to endocrine disruptors;
Amendment 113 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Calls on the Commission to carry out a systematic examination of all relevant current legislation and, where necessary, to propose new legislation so as to reduce the exposure of human beings, particularly foetuses, babies, children and teenagers, to hormone disruptors; calls on the Commission to submit legislative proposals for chemicals inreview inter alia the EU legislation relating to cosmetics, textiles and, building materials, and stresses in particular the importance of reviewing legislation onelectronic goods, toys safety, materials and products intended to come into contact with food, so as to reduce human exposure to endocrine disrupto– including packaging, and safety and health of pregnant workers;.
Amendment 122 #
Motion for a resolution
Paragraph 12 a (new)
Paragraph 12 a (new)
12a. Calls on the Commission, when carrying out its future review of EU strategy on endocrine disruptors, to lay down an exact timetable, specifying the intermediate stages, for the purposes of: – applying the future criteria serving to identify possible endocrine-disrupting chemicals; – reviewing the relevant legislation referred to in paragraph 12; – publishing a regularly updated list of priority endocrine disruptors, the first version of which should be published by 20 December 2014; – taking all measures necessary to reduce the exposure of the EU public and the environment to endocrine disruptors;
Amendment 140 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Calls on the Commission to support targeted research projects on endocrine disruptors, including the development of new testing and analysis methods; calls on the Commission to incorporate endocrine disruptors, their combination effects, and related subjects in the priorities for the research and development framework programme;
Amendment 149 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Calls on the Commission to include all relevant stakeholders in cooperation seeking to adopt the necessary legislative changes to improve protection of human health and environment from hormone- disrupting chemicals;
Amendment 150 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Calls on the Commission to include all relevant stakeholders in cooperation seeking to adopt the necessary legislative changes to improve protection of human health from hormone-disrupting chemicals and to devise information campaigns;
Amendment 155 #
Motion for a resolution
Paragraph 17 a (new)
Paragraph 17 a (new)
17 a. Welcomes the inclusion of EDCs as an emerging policy issue under the Strategic Approach to International Chemicals Management (SAICM); calls on the Commission and the Member States to support these SAICM activities, and to promote active policies to reduce human and environment exposure to EDCs in all relevant international forums as World Health Organization (WHO) or the United Nations Environment Programme (UNEP).
Amendment 156 #
Motion for a resolution
Paragraph 17 b (new)
Paragraph 17 b (new)
17 b. Calls on the Commission and member states to launch public information campaigns to improve the level of information of the general public, especially vulnerable populations, on endocrine disrupters used in consumer products ; calls on member states to improve the training programs of health professionals in this field.